Gestational Diabetes. high-risk pregnancy
Conditions
Interventions
Intervention 1: Intervention group: to prevent miscarriage and preterm delivery, had administration of oral Dydrogesterone 10 mg twice daily for intervention group. Intervention 2: Control group:the 5
Treatment - Drugs
Placebo
Intervention group: to prevent miscarriage and preterm delivery, had administration of oral Dydrogesterone 10 mg twice daily for intervention group
Control group:the 50 women who did not use oral dydrogesterone formed the control group.
Sponsors
Vice Chancellor Of Research, Shiraz University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
14 Years to 30 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: singleton pregnancy, the absence of any systemic disease, age less than 30 years, BMI less than 25, no history of stillbirth, having a family history of diabetes Exclusion criteria: smoking, history of diabetes, gestational diabetes and other systemic diseases, any fetal abnormalities on ultrasound, multiple pregnancy, previous macrosomia
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| FBS. Timepoint: At Gestational age 14 weeks. Method of measurement: Gelocometer. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactBehnaz Karami
Shiraz University of Medical Sciences
Outcome results
None listed